MedPath

The relation between HbA1c level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas.

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000025284
Lead Sponsor
Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine
Brief Summary

The duration of hypoglycemia with glucose values of less than 70 mg/dL was 6.8 , 2.6 , 1.8 , 1.6 , and 0.4 min/h for HbA1c levels of no more than 6.4%, 6.5 to 6.9%, 7.0 to 7.4%, 7.5 to 7.9%, and 8.0% and over, respectively, and was significantly (P less than 0.0125) longer in the HbA1c no more than 6.4%, 6.5 to 6.9%, and 7.0 to 7.4% groups than in the 8.0% and more group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

treated with insulin

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Association between time of hypoglycemic range(min/day) and levels of HbA1c
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath